Provisional patent for weight loss compound
Friday, 27 February, 2009
Diagnostics company HealthLinx and industry group Dairy Australia have filed a provisional patent for a dairy-derived bioactive compound that has shown weight loss potential in rats.
The compound, LAP001, was identified from fractionated proteins in dairy products. It was found to reduce the production and storage of fat in rat cells.
The activity was confirmed by an independent research institute, HealthLinx said in a statement. Further analysis is being undertaken.
HealthLinx said there was the potential to develop the compound as a nutraceutical.
Reproductive impacts of PFAS exposure revealed
New studies have found that PFAS exposure can significantly alter male reproductive health, and...
'Longevity gene' could reverse damage from rapid aging disease
A gene found in supercentenarians, who live exceptionally long lives, could counteract the...
How a common gene mutation increases liver disease risk
Liver damage can be caused in people after exposure to high levels of acrolein, especially in...
